Dr. Bikdeli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis Street
Boston, MA 02115Phone+1 617-732-5500Fax+1 617-732-5500
Education & Training
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2016
- Shahid Beheshti University of Medical SciencesClass of 2008
Certifications & Licensure
- MA State Medical License 2020 - 2025
- NY State Medical License 2017 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 1871 citationsExtrapulmonary manifestations of COVID-19.Aakriti Gupta, Mahesh V. Madhavan, Kartik Sehgal, Nandini Nair, Shiwani Mahajan
Nature Medicine. 2020-07-10 - 9 citationsMachine Learning to Predict Outcomes in Patients with Acute Pulmonary Embolism Who Prematurely Discontinued Anticoagulant Therapy.Damian Mora, J.A. Nieto, J. Mateo, Behnood Bikdeli, Stefano Barco
Thrombosis and Haemostasis. 2021-06-09 - 16 citationsVenous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.Behnood Bikdeli, David Jiménez, Pablo Demelo-Rodriguez, Francisco Galeano-Valle, José Antonio Porras
Viruses. 2022-01-18
Journal Articles
- Sulodexide Versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized TrialsBehnood Bikdeli, MD, Thieme
- Clinical Investigations Thirty-Day Outcomes in Patients with Acute Pulmonary Embolism Who Discontinued Anticoagulant Therapy Before 90 DaysBehnood Bikdeli, MD, ScienceDirect
Abstracts/Posters
- [Board 365] Cardiovascular Events in Patients Receiving Sulodexide Versus Control: Systematic Review and Meta-Analysis of Randomized Controlled TrialsBehnood Bikdeli, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
- [Board 423] Non-Inferiority Trials With a Primary Surrogate Endpoint: An Increasing Phenotype in Cardiovascular TrialsBehnood Bikdeli, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Lectures
- Pulmonary Embolism Hospitalizations and Use of Inferior Vena Caval Filters in Older AdultsNational Study of Medicare Beneficiaries -2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
- Venous Thromboembolism in Patients With Liver CirrhosisFindings From the RIETE Registry -2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Authored Content
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up JACC State-of-the-Art ReviewJune 2020
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up JACC State-of-the-Art ReviewJune 2020
Press Mentions
- Different Guidelines for Acute PE Offer a Mixed Bag of AdviceOctober 8th, 2024
- Platelet Hyperreactivity Score May Improve CVD Risk DetectionAugust 23rd, 2024
- Warfarin Best for Thrombotic Antiphospholipid Syndrome?January 11th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: